Water Network Perturbation in Ligand Binding: Adenosine A2A Antagonists as a Case Study

Recent efforts in the computational evaluation of the thermodynamic properties of water molecules have resulted in the development of promising new in silico methods to evaluate the role of water in ligand binding. These methods include WaterMap, SZMAP, GRID/CRY probe, and Grand Canonical Monte Carlo simulations. They allow the prediction of the position and relative free energy of the water molecule in the protein active site and the analysis of the perturbation of an explicit water network (WNP) as a consequence of ligand binding. We have for the first time extended these approaches toward the prediction of kinetics for small molecules and of relative free energy of binding with a focus on the perturbation of the water network and application to large diverse data sets. Our results support a qualitative correlation between the residence time of 12 related triazine adenosine A(2A) receptor antagonists and the number and position of high energy trapped solvent molecules. From a quantitative viewpoint, we successfully applied these computational techniques as an implicit solvent alternative, in linear combination with a molecular mechanics force field, to predict the relative ligand free energy of binding (WNP-MMSA). The applicability of this linear method, based on the thermodynamics additivity principle, did not extend to 375 diverse A(2A) receptor antagonists. However, a fast but effective method could be enabled by replacing the linear approach with a machine learning technique using probabilistic classification trees, which classified the binding affinity correctly for 90% of the ligands in the training set and 67% in the test set.

[1]  Andrea Bortolato,et al.  New insights from structural biology into the druggability of G protein-coupled receptors. , 2012, Trends in pharmacological sciences.

[2]  Gabriele Cruciani,et al.  A Common Reference Framework for Analyzing/Comparing Proteins and Ligands. Fingerprints for Ligands And Proteins (FLAP): Theory and Application , 2007, J. Chem. Inf. Model..

[3]  Paul D Lyne,et al.  Accurate prediction of the relative potencies of members of a series of kinase inhibitors using molecular docking and MM-GBSA scoring. , 2006, Journal of medicinal chemistry.

[4]  P. Ball Water as an active constituent in cell biology. , 2008, Chemical reviews.

[5]  A. Warshel,et al.  Calculations of antibody-antigen interactions: microscopic and semi-microscopic evaluation of the free energies of binding of phosphorylcholine analogs to McPC603. , 1992, Protein engineering.

[6]  K. Kosik,et al.  Structure-activity relationship study of 2,4-diaminothiazoles as Cdk5/p25 kinase inhibitors. , 2011, Bioorganic & medicinal chemistry letters.

[7]  Leo Breiman,et al.  Random Forests , 2001, Machine Learning.

[8]  N. Vermeulen,et al.  The role of water molecules in computational drug design. , 2010, Current topics in medicinal chemistry.

[9]  J. Ballesteros,et al.  [19] Integrated methods for the construction of three-dimensional models and computational probing of structure-function relations in G protein-coupled receptors , 1995 .

[10]  Robert A Copeland,et al.  The dynamics of drug-target interactions: drug-target residence time and its impact on efficacy and safety , 2010, Expert opinion on drug discovery.

[11]  Junmei Wang,et al.  Development and testing of a general amber force field , 2004, J. Comput. Chem..

[12]  Martin Smiesko,et al.  AcquaAlta: A Directional Approach to the Solvation of Ligand-Protein Complexes , 2011, J. Chem. Inf. Model..

[13]  Jonathan S. Mason,et al.  Progress in Structure Based Drug Design for G Protein-Coupled Receptors , 2011, Journal of medicinal chemistry.

[14]  Cristiano Ruch Werneck Guimarães,et al.  Addressing Limitations with the MM-GB/SA Scoring Procedure using the WaterMap Method and Free Energy Perturbation Calculations , 2010, J. Chem. Inf. Model..

[15]  P. Kollman,et al.  Calculating structures and free energies of complex molecules: combining molecular mechanics and continuum models. , 2000, Accounts of chemical research.

[16]  Luísa V. Lopes,et al.  Adenosine and related drugs in brain diseases: present and future in clinical trials. , 2011, Current topics in medicinal chemistry.

[17]  W. L. Jorgensen,et al.  Comparison of simple potential functions for simulating liquid water , 1983 .

[18]  T. N. Bhat,et al.  The Protein Data Bank , 2000, Nucleic Acids Res..

[19]  Fumio Hirata,et al.  Placevent: An algorithm for prediction of explicit solvent atom distribution—Application to HIV‐1 protease and F‐ATP synthase , 2012, J. Comput. Chem..

[20]  Mei Liu,et al.  Prediction of protein-protein interactions using random decision forest framework , 2005, Bioinform..

[21]  R. Copeland Conformational adaptation in drug-target interactions and residence time. , 2011, Future medicinal chemistry.

[22]  Julien Michel,et al.  Prediction of the water content in protein binding sites. , 2009, The journal of physical chemistry. B.

[23]  Woody Sherman,et al.  New hypotheses about the structure–function of proprotein convertase subtilisin/kexin type 9: Analysis of the epidermal growth factor‐like repeat A docking site using WaterMap , 2010, Proteins.

[24]  R. Copeland,et al.  Drug–target residence time and its implications for lead optimization , 2007, Nature Reviews Drug Discovery.

[25]  Fumio Hirata,et al.  Locating missing water molecules in protein cavities by the three‐dimensional reference interaction site model theory of molecular solvation , 2006, Proteins.

[26]  Loriano Storchi,et al.  New and Original pKa Prediction Method Using Grid Molecular Interaction Fields , 2007, J. Chem. Inf. Model..

[27]  C. Tate,et al.  Thermostabilisation of an Agonist-Bound Conformation of the Human Adenosine A2A Receptor , 2011, Journal of molecular biology.

[28]  C. Higgs,et al.  Hydration Site Thermodynamics Explain SARs for Triazolylpurines Analogues Binding to the A2A Receptor. , 2010, ACS medicinal chemistry letters.

[29]  Lingle Wang,et al.  Ligand binding to protein-binding pockets with wet and dry regions , 2011, Proceedings of the National Academy of Sciences.

[30]  Pál Pacher,et al.  Adenosine receptors: therapeutic aspects for inflammatory and immune diseases , 2006, Nature Reviews Drug Discovery.

[31]  K. Palczewski,et al.  Role of Bulk Water in Hydrolysis of the Rhodopsin Chromophore* , 2011, The Journal of Biological Chemistry.

[32]  K A Dill,et al.  Additivity Principles in Biochemistry* , 1997, The Journal of Biological Chemistry.

[33]  Loriano Storchi,et al.  Tautomer Enumeration and Stability Prediction for Virtual Screening on Large Chemical Databases , 2009, J. Chem. Inf. Model..

[34]  Felice C. Lightstone,et al.  Accounting for water molecules in drug design , 2011, Expert opinion on drug discovery.

[35]  Leonardo Pardo,et al.  The Role of Internal Water Molecules in the Structure and Function of the Rhodopsin Family of G Protein‐Coupled Receptors , 2007, Chembiochem : a European journal of chemical biology.

[36]  Nathan Robertson,et al.  Biophysical Mapping of the Adenosine A2A Receptor , 2011, Journal of medicinal chemistry.

[37]  Albert C. Pan,et al.  Molecular determinants of drug-receptor binding kinetics. , 2013, Drug discovery today.

[38]  Caterina Barillari,et al.  Classification of water molecules in protein binding sites. , 2007, Journal of the American Chemical Society.

[39]  Woody Sherman,et al.  Contributions of water transfer energy to protein‐ligand association and dissociation barriers: Watermap analysis of a series of p38α MAP kinase inhibitors , 2013, Proteins.

[40]  Mihaly Mezei,et al.  Simulated Annealing of Chemical Potential: A General Procedure for Locating Bound Waters. Application to the Study of the Differential Hydration Propensities of the Major and Minor Grooves of DNA , 1996 .

[41]  Urban Bren,et al.  Individual degrees of freedom and the solvation properties of water. , 2012, The Journal of chemical physics.

[42]  R. Stevens,et al.  Structure of an Agonist-Bound Human A2A Adenosine Receptor , 2011, Science.

[43]  John B. O. Mitchell,et al.  A machine learning approach to predicting protein-ligand binding affinity with applications to molecular docking , 2010, Bioinform..

[44]  R. Woods,et al.  Involvement of water in carbohydrate-protein binding. , 2001, Journal of the American Chemical Society.

[45]  Woody Sherman,et al.  Contribution of Explicit Solvent Effects to the Binding Affinity of Small‐Molecule Inhibitors in Blood Coagulation Factor Serine Proteases , 2011, ChemMedChem.

[46]  James E. J. Mills,et al.  High-Throughput Virtual Screening of Proteins Using GRID Molecular Interaction Fields , 2010, J. Chem. Inf. Model..

[47]  Holger Gohlke,et al.  Converging free energy estimates: MM‐PB(GB)SA studies on the protein–protein complex Ras–Raf , 2004, J. Comput. Chem..

[48]  Araz Jakalian,et al.  Fast, efficient generation of high‐quality atomic charges. AM1‐BCC model: I. Method , 2000 .

[49]  R. Stevens,et al.  Structural Basis for Allosteric Regulation of GPCRs by Sodium Ions , 2012, Science.

[50]  Teruki Honma,et al.  Combining Machine Learning and Pharmacophore-Based Interaction Fingerprint for in Silico Screening , 2010, J. Chem. Inf. Model..

[51]  PatrickY.-S. Lam,et al.  Rational design of potent, bioavailable, nonpeptide cyclic ureas as HIV protease inhibitors. , 1994, Science.

[52]  A. Leslie,et al.  Agonist-bound adenosine A2A receptor structures reveal common features of GPCR activation , 2011, Nature.

[53]  Gregory A Ross,et al.  Rapid and Accurate Prediction and Scoring of Water Molecules in Protein Binding Sites , 2012, PloS one.

[54]  Paolo Carnevali,et al.  Fragment-Based Computation of Binding Free Energies by Systematic Sampling , 2009, J. Chem. Inf. Model..

[55]  D. J. Adams,et al.  Chemical potential of hard-sphere fluids by Monte Carlo methods , 1974 .

[56]  Helgi B. Schiöth,et al.  Structural diversity of G protein-coupled receptors and significance for drug discovery , 2008, Nature Reviews Drug Discovery.

[57]  Urban Bren,et al.  Decomposition of the solvation free energies of deoxyribonucleoside triphosphates using the free energy perturbation method. , 2006, The journal of physical chemistry. B.

[58]  K. Jacobson,et al.  Adenosine receptors as therapeutic targets , 2006, Nature Reviews Drug Discovery.

[59]  Richard A. Friesner,et al.  Docking performance of the glide program as evaluated on the Astex and DUD datasets: a complete set of glide SP results and selected results for a new scoring function integrating WaterMap and glide , 2012, Journal of Computer-Aided Molecular Design.

[60]  P. Kollman,et al.  How well does a restrained electrostatic potential (RESP) model perform in calculating conformational energies of organic and biological molecules? , 2000 .

[61]  G Vriend,et al.  WHAT IF: a molecular modeling and drug design program. , 1990, Journal of molecular graphics.

[62]  F. Micheli,et al.  Preladenant in patients with Parkinson's disease and motor fluctuations: a phase 2, double-blind, randomised trial , 2011, The Lancet Neurology.

[63]  Klaus R. Liedl,et al.  A GRID-Derived Water Network Stabilizes Molecular Dynamics Computer Simulations of a Protease , 2011, J. Chem. Inf. Model..

[64]  A. Kruse,et al.  Structure of the human M2 muscarinic acetylcholine receptor bound to an antagonist , 2011, Nature.

[65]  Mark R. Chance,et al.  Structural waters define a functional channel mediating activation of the GPCR, rhodopsin , 2009, Proceedings of the National Academy of Sciences.

[66]  Urban Bren,et al.  Do all pieces make a whole? Thiele cumulants and the free energy decomposition , 2007 .

[67]  R. Copeland,et al.  Residence time of receptor-ligand complexes and its effect on biological function. , 2008, Biochemistry.

[68]  P. Goodford A computational procedure for determining energetically favorable binding sites on biologically important macromolecules. , 1985, Journal of medicinal chemistry.

[69]  J. Aqvist,et al.  A new method for predicting binding affinity in computer-aided drug design. , 1994, Protein engineering.

[70]  Chris Oostenbrink,et al.  Cytochrome P450 3A4 Inhibition by Ketoconazole: Tackling the Problem of Ligand Cooperativity Using Molecular Dynamics Simulations and Free-Energy Calculations , 2012, J. Chem. Inf. Model..

[71]  S. Iwata,et al.  G protein-coupled receptor inactivation by an allosteric inverse-agonist antibody , 2011, Nature.

[72]  Matthew P. Repasky,et al.  Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. , 2004, Journal of medicinal chemistry.

[73]  S. Moro,et al.  The ATP‐Binding Site of Protein Kinase CK2 Holds a Positive Electrostatic Area and Conserved Water Molecules , 2007, Chembiochem : a European journal of chemical biology.

[74]  Benoît Roux,et al.  Grand canonical Monte Carlo simulations of water in protein environments. , 2004, The Journal of chemical physics.

[75]  B. Berne,et al.  Role of the active-site solvent in the thermodynamics of factor Xa ligand binding. , 2008, Journal of the American Chemical Society.

[76]  Urban Bren,et al.  DNA duplex stability: the role of preorganized electrostatics. , 2010, The journal of physical chemistry. B.

[77]  Stefano Moro,et al.  In Silico Binding Free Energy Predictability by Using the Linear Interaction Energy (LIE) Method: Bromobenzimidazole CK2 Inhibitors as a Case Study , 2007, J. Chem. Inf. Model..

[78]  R. Stevens,et al.  The 2.6 Angstrom Crystal Structure of a Human A2A Adenosine Receptor Bound to an Antagonist , 2008, Science.

[79]  Ricardo L Mancera Molecular modeling of hydration in drug design. , 2007, Current opinion in drug discovery & development.

[80]  Nathan Robertson,et al.  Article pubs.acs.org/jmc Identification of Novel Adenosine A 2A Receptor Antagonists by Virtual Screening , 2022 .

[81]  M. Congreve,et al.  Structure of the adenosine A(2A) receptor in complex with ZM241385 and the xanthines XAC and caffeine. , 2011, Structure.

[82]  Jonathan S. Mason,et al.  Discovery of 1,2,4-Triazine Derivatives as Adenosine A2A Antagonists using Structure Based Drug Design , 2012, Journal of medicinal chemistry.

[83]  F. J. Luque,et al.  Shielded hydrogen bonds as structural determinants of binding kinetics: application in drug design. , 2011, Journal of the American Chemical Society.